(Q33541092)

27 July 2017

1 reference

title

Dendritic cells: a novel therapeutic modality (English)

1 reference

27 July 2017

1 reference

J Wagstaff

4

0 references

author name string

S A Luykx-de Bakker

1

1 reference

27 July 2017

T D de Gruijl

2

1 reference

27 July 2017

R J Scheper

3

1 reference

27 July 2017

H M Pinedo

5

1 reference

27 July 2017

publication date

1 January 1999

1 reference

27 July 2017

1 reference

27 July 2017

volume

10

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

21-27

1 reference

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Tolerance, danger, and the extended family

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

The dendritic cell system and its role in immunogenicity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Origin, maturation and antigen presenting function of dendritic cells.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Dendritic cell development in culture from thymic precursor cells in the absence of granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Mannose receptor mediated antigen uptake and presentation in human dendritic cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

A new foreign policy: MHC class I molecules monitor the outside world

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

P-glycoprotein--a marker of cancer-cell behavior

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Dendritic cells in immune response induction

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Checkpoints and functional stages in DC maturation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-alpha, but strongly enhanced by interleukin-10.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Dendritic cells: origin and differentiation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Infiltration of dendritic cells into regional lymph nodes in gastric cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Roles of Langerhans' cells and T-lymphocytes infiltrating cancer tissues in patients treated by radiation therapy for cervical cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

HLA-DR antigen- and S-100 protein-positive dendritic cells in esophageal squamous cell carcinoma--their distribution in relation to prognosis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

The host-tumor immune conflict: from immunosuppression to resistance and destruction

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Dendritic Cells Genetically Modified with an Adenovirus Vector Encoding the cDNA for a Model Antigen Induce Protective and Therapeutic Antitumor Immunity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary Metastases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Efficient Retrovirus-Mediated Gene Transfer of Dendritic Cells Generated from CD34+Cord Blood Cells under Serum-Free Conditions

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Human tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Immunotherapy of cancer with dendritic-cell-based vaccines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Antigen-presenting cells pulsed with unfractionated tumor-derived peptides are potent tumor vaccines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Genetically modified bone marrow‐derived dendritic cells expressing tumor‐associated viral or “self” antigens induce antitumor immunity in vivo

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Dendritic cell surface molecules. A proliferating field.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Phenotypic and functional differences between human dendritic cells derived in vitro from hematopoietic progenitors and from monocytes/macrophages.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008349920664

7 January 2021

Identifiers

DOI

10.1023/A:1008349920664

1 reference

27 July 2017

1 reference